Search

Displaying results 3331 - 3340 of 7062 in total
  1. Drug

    Levamlodipine

    go.drugbank.com/drugs/DB09237
    ApprovedInvestigational

    [A188940] Levamlodipine was granted FDA approval on 19 December 2019.[L10833] … [L10833] This medication was first marketed in Russia and India before being granted FDA approval.

  2. Drug

    Coagulation factor X human

    go.drugbank.com/drugs/DB13148
    ApprovedInvestigational

    It is a two-chain glycoprotein with the molecular weight of approximately 59 kDa [A31472]. … Coagulation Factor X is a vitamin K-dependent, liver-produced serine protease that serves as the first enzyme in the coagulation cascade to form fibrin.

  3. Drug

    Estradiol dienanthate

    go.drugbank.com/drugs/DB13955
    ApprovedVet approvedWithdrawn

    Estradiol Dienanthate is a pro-drug ester of [DB00783], a naturally occurring hormone that circulates endogenously within the human body. … First-pass metabolism by the gut and the liver quickly degrades the estradiol molecule before it gets a chance to enter systemic circulation and exert its estrogenic effects [A12102].

  4. Drug

    Tocilizumab

    go.drugbank.com/drugs/DB06273
    ApprovedInvestigational

    [L44483] Tocilizumab-bavi, a biosimilar drug, was approved by the FDA in September 2023.[L48385]. … [A193281] Tocilizumab was granted FDA approval on 8 January 2010 to treat a number of inflammatory and autoimmune disorders, such as different types of arthritis and cytokine release syndrome.

  5. Drug

    Pincainide

    go.drugbank.com/drugs/DB20097
    Experimental

    Pincainide has a monoisotopic molecular weight of 260.19 Da. … Pincainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Pincainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  6. Drug

    Pratosartan

    go.drugbank.com/drugs/DB20100
    Experimental

    Pratosartan has a monoisotopic molecular weight of 426.22 Da. … Pratosartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Pratosartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).

  7. Drug

    Ketazocine

    go.drugbank.com/drugs/DB20132
    Experimental

    Ketazocine has a monoisotopic molecular weight of 285.17 Da. … Ketazocine is a small molecule drug. The usage of the INN stem '-azocine' in the name indicates that Ketazocine is a narcotic antagonist/agonist related to 6,7-benzomorphan.

  8. Drug

    Zolasartan

    go.drugbank.com/drugs/DB20140
    Experimental

    Zolasartan has a monoisotopic molecular weight of 554.05 Da. … Zolasartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Zolasartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).

  9. Drug

    Ecomustine

    go.drugbank.com/drugs/DB20177
    Experimental

    Ecomustine has a monoisotopic molecular weight of 311.09 Da. … Ecomustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Ecomustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  10. Drug

    Itrocainide

    go.drugbank.com/drugs/DB20210
    Experimental

    Itrocainide has a monoisotopic molecular weight of 361.22 Da. … Itrocainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Itrocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.